The historical rank and industry rank for DSM-Firmenich AG's ROE % or its related term are showing as below:
XSWX:DSFIR'
s ROE % Range Over the Past 10 Years
Min: -5.3 Med: 1.1 Max: 9.33
Current: -5.22
During the past 4 years, DSM-Firmenich AG's highest ROE % was 9.33%. The lowest was -5.30%. And the median was 1.10%.
XSWX:DSFIR's ROE % is ranked worse than 81.95% of 1590
companies
in the Chemicals industry
Industry Median: 5.195
vs XSWX:DSFIR: -5.22
DSM-Firmenich AG (XSWX:DSFIR) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
DSM-Firmenich AG ROE % Related Terms
DSM-Firmenich AG ROE % Historical Data
* Premium members only.
The historical data trend for DSM-Firmenich AG's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, DSM-Firmenich AG's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DSM-Firmenich AG ROE % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, DSM-Firmenich AG's ROE % distribution charts can be found below:
* The bar in red indicates where DSM-Firmenich AG's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
DSM-Firmenich AG (XSWX:DSFIR) has a ROE % of -16.03% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on DSM-Firmenich AG and its competitors. According to the industry distribution chart, DSM-Firmenich AG ranks #1303 out of 1590 companies in the Chemicals industry, placing it in the top 81.9%.
Is DSM-Firmenich AG's ROE % too high?
DSM-Firmenich AG's current ROE % is -16.03%. Based on the distribution chart, DSM-Firmenich AG ranks #1303 out of 1590 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, DSM-Firmenich AG has a GF Score™ of 31/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's ROE % compare to LIN and SHW?
According to the Chemicals industry distribution chart, DSM-Firmenich AG ranks #1303 out of 1590 companies for ROE %. This places DSM-Firmenich AG in the lower half of its industry. The industry median ROE % is 5.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Chemicals company?
The median ROE % among Chemicals companies is 5.20, based on 1,590 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on DSM-Firmenich AG and its competitors. For the Chemicals industry, the median ROE % is 5.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DSM-Firmenich AG's current ROE % is -16.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (XSWX:DSFIR) is currently considered Fairly Valued. The stock's GF Value™ is CHF70.59, compared to a current price of CHF74.82 — trading 6% above its estimated fair value. The current ROE % is -16.03%. DSM-Firmenich AG's overall GF Score™ is 31/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For DSM-Firmenich AG (XSWX:DSFIR), the current ROE % is -16.03% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DSM-Firmenich AG (XSWX:DSFIR) Overvalued in 2026?
Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued.
The current stock price of CHF74.82 is trading 6% above its estimated GF Value™ of CHF70.59.
GuruFocus considers DSM-Firmenich AG to be Fairly Valued.
Key valuation signals for XSWX:DSFIR:
ROE %: -16.03%
GF Value™: CHF70.59 vs. price of CHF74.82 (6% above fair value)
No single metric tells the full story. See the XSWX:DSFIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
31GF Score
Get the complete analysis for XSWX:DSFIR
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DSFIR has been successfully added to your 